Browsing: SCLC

Tambotatug pelitecan is a novel antibody-drug conjugate that delivers a topoisomerase I inhibitor to (typically malignant) cells highly-expressing the immune…

When patients with ES-SCLC develop brain only progression, should they switch systemic therapy along with brain radiation? This multicenter cohort…

Headline: Does thoracic radiation improve survival for extensive stage SCLC in the immunotherapy era?The Study: In the pre-immunotherapy era, the…

Top Line: Does the addition of atezolizumab to chemoradiation improve survival in limited stage small cell lung cancer?The Study: The…

Does consolidative thoracic radiation improve survival in the setting of immunotherapy for extensive stage SCLC? This systematic review and meta-analysis…

Top Line: Who needs a refresher on current guidelines for the management of small cell lung cancer (SCLC)?The Study: This…

A NCDB analysis reports the use of more advanced brain radiation techniques such as stereotactic radiosurgery and hippocampal-avoidance whole brain…

Headline: The addition of atezolizumab to definitive chemoradiation for limited-stage small cell lung cancer (LS-SCLC) is a big letdown.The Study:…

Originally reported at ASCO earlier this year, here is the full publication of the ADRIATIC trial. In this randomized, phase…

The natural next space for immune checkpoint inhibitors to enter is outback following definitive chemoradiation for limited-stage small cell lung…